Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Merck sees Oxytrol OTC as cushion against Rx patent expirations; Pfizer acquisitions boost consumer sales 16% in Q4; Latin America stands out for Mead Johnson.
You may also be interested in...
Mead Johnson Hopes To Milk JV For Latin American Growth
An 80-20 joint venture with dairy producer SanCor likely will help Mead Johnson cement its footprint in Argentina and other Latin American countries. Meanwhile, the pediatric nutritionals firm maintains muted expectations for the U.S. in 2012.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.